Clinical trial

Proper Dosage of Ketamine in Intravenous Regional Anesthesia

NCT00221871 · University Health Network, Toronto, Other · Unknown status

Key facts

NCT number NCT00221871
Title Proper Dosage of Ketamine in Intravenous Regional Anesthesia
Official title Proper Dosage of Intravenous Ketamine When Used as an Adjuvant to Lidocaine in Intravenous Regional Anesthesia (IVRA).
Lead sponsor University Health Network, Toronto, Other
Status Unknown status
Study type Interventional
Conditions Pain.
Intervention type Drug
Interventions Different dosages of Ketamine
Start date Jan 1, 2004
Completion Jan 1, 2005
First posted Sep 22, 2005
Last update posted Oct 11, 2006
Countries Canada

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies